IceCure Medical Ltd (ICCM) Stock Score, Valuation & Financial Research
IceCure Medical Ltd is in the Healthcare sector and Medical - Devices industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 30/100.
Quick answer for ICCM
IceCure Medical Ltd currently has a Wall Street Score of 30/100. The stored market price is $2.21. Its financial score is 35/100. Its valuation score is 0/100. The latest WSS change is +3.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What IceCure Medical Ltd does
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
ICCM financial snapshot
- Wall Street Score:
- 30/100
- Current price:
- $2.21
- Market capitalization:
- $5.0M
- Revenue:
- $3.9M
- Net income:
- $-16.9M
- Free cash flow:
- $-14.6M
- Cash:
- $12.0M
- Total debt:
- $90K
- EPS:
- -7.10
- Financial score:
- 35/100
- Valuation score:
- 0/100
- Revenue score:
- 23/100
What stands out
- Reported year-over-year revenue growth is +0.2%.
- Free cash flow is $-14.6M, showing cash burn in the current stored period.
- The balance sheet shows $12.0M of cash versus $90K of total debt, leaving more cash than debt.
- The latest Wall Street Score change is +3.1 points: ICCM increased 3.1 points because Revenue improved by 11.1 points, Management improved by 20 points, Buffett improved by 5.2 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 35/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research ICCM
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.